Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host cell entry receptors for HSV-1 are a diverse group of cell surface molecules that facilitate the multi-step process of viral attachment and penetration into various human tissues. The entry process typically begins with the virus binding to heparan sulfate proteoglycans (HSPG) for initial attachment, followed by the specific interaction of viral glycoprotein D (gD) with one of three primary receptors: Nectin-1 (a cell adhesion molecule), Herpesvirus Entry Mediator (HVEM, a TNF receptor superfamily member), or 3-O-sulfated heparan sulfate. Additionally, other host factors such as PILR-alpha, NMHC-IIA, and MAG interact with viral glycoprotein B (gB) to trigger the fusion of the viral envelope with the host cell membrane. These receptors determine the tissue tropism of the virus, with Nectin-1 being the primary receptor in epithelial and neuronal cells, while HVEM is prominent in lymphoid cells. Because these receptors are essential for the establishment of both lytic and latent infections, they are significant targets for antiviral drug development. Therapeutic strategies include the use of entry inhibitors like docosanol, which disrupts membrane fusion, and experimental agents such as peptides or small molecules that block specific glycoprotein-receptor interactions. However, targeting these host proteins poses challenges due to their endogenous roles in immune signaling and cell-cell adhesion.
Inhibition of viral-host membrane fusion, competitive inhibition of viral attachment to heparan sulfate, and downregulation of receptor expression.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Herpes simplex virus 1 host cell entry receptors (HSV-1 entry receptors).